Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LAE102 + Tirzepatide in Obese Participants
NCT07671391Phase 2Not yet recruiting
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Aug 2026
- Primary completion
- Jul 2027
01
Overview
A Phase 2 trial of LAE102 in obesity, sponsored by Zhongshan Hospital, Fudan University. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
LAE102
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07671391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07671391.